Pharmaceuticals, Biotechnology and Life Sciences
Kodiak Sciences will present emerging data from the Phase 1b clinical study of KSI-301 in treatment-naïve patients with neovascular age-related macular degeneration (wet AMD), Diabetic Macular Edema (DME), and Retinal Vein Occlusion (RVO) in San Francisco, in an upcoming event, at the Annual Meeting of the American Academy of Ophthalmology (AAO).
Nevakar, ophthalmology specialist pharmaceutical company has entered into a $17.5 million product financing agreement with an affiliate of H.I.G. Capital Partners, L.P. for the continued development of five differentiated, sterile injectable products.
PRINCETON, N.J.–(BUSINESS WIRE)–Oyster Point Pharma, Inc., a privately held clinical-stage pharmaceutical company with an initial focus on developing novel therapies…
Global Ophthalmology Therapeutics Market 2019-2023 – Key Players are Allergan, F. Hoffmann-La Roche, Novartis, Regeneron Pharmaceuticals, and Santen Pharmaceutical
NIH-funded clinical trial shows use of either drug improved vision and had few side effects.
Johnson & Johnson has completed the acquisition of Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott for $4.325 billion